Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

636
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
636
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

994
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
994
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.0K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.0K
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

560
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
560
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

327
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
327
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

240
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
240

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methylation and polygenic risk scores capture different features of systemic lupus erythematosus.

Rheumatology (Oxford, England)·2026
Same author

Extracellular vesicles exposing complement split products are associated with kidney involvement in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

RMD open·2026
Same author

Risk stratification according to genotype and effect of thromboprophylaxis on obstetric outcomes in women with antithrombin deficiency.

Research and practice in thrombosis and haemostasis·2026
Same author

Comparison of BAFF and type I IFN activity in blood and placenta in SLE and healthy pregnancies.

Lupus science & medicine·2026
Same author

Second delivery rates and recurrence of adverse pregnancy outcomes in women with systemic lupus erythematosus: a nationwide population-based cohort study.

Rheumatology (Oxford, England)·2026
Same author

Extracellular Matrix Remodelling in the Human Sural Nerve in Peripheral Vascular Disease.

Medicina (Kaunas, Lithuania)·2026

Related Experiment Video

Updated: Feb 3, 2026

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.8K

Obstetric antiphospholipid syndrome.

Aleksandra Antovic1, Maria Sennström2, Katarina Bremme2

  • 1Unit of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Lupus Science & Medicine
|October 27, 2018
PubMed
Summary

Antiphospholipid syndrome (APS) in pregnancy requires prompt diagnosis and treatment for successful outcomes. Early intervention in obstetric APS (OAPS) improves maternal and infant health and reduces long-term risks.

Keywords:
antiphospholipid antibodieslupus anticoagulantobstetric antiphospholipid syndromesystemic lupus erythematosustreatment obstetric antiphospholipid syndrome

More Related Videos

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
08:31

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Published on: July 31, 2016

14.5K
Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.5K

Related Experiment Videos

Last Updated: Feb 3, 2026

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.8K
Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
08:31

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Published on: July 31, 2016

14.5K
Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.5K

Area of Science:

  • Obstetrics and Gynecology
  • Rheumatology
  • Immunology

Background:

  • Antiphospholipid syndrome (APS) classification criteria were established in 2006.
  • Obstetric APS (OAPS) is characterized by antiphospholipid antibodies and adverse pregnancy outcomes.
  • Timely diagnosis and treatment of OAPS are crucial for successful pregnancies.

Purpose of the Study:

  • To review current knowledge on obstetric antiphospholipid syndrome (OAPS).
  • To update on pathogenesis, risk factors, and outcomes for OAPS.
  • To discuss treatment strategies and long-term implications for OAPS patients.

Main Methods:

  • Literature review focusing on obstetric antiphospholipid syndrome (OAPS).
  • Analysis of clinical and laboratory data related to OAPS.
  • Synthesis of information on pathogenesis, risk factors, and treatment.

Main Results:

  • OAPS diagnosis involves antiphospholipid antibodies and pregnancy complications like fetal loss or pre-eclampsia.
  • Effective treatment enables successful pregnancies in most OAPS patients.
  • OAPS patients may face increased thrombotic event risk.

Conclusions:

  • Obstetric antiphospholipid syndrome (OAPS) necessitates specialized management.
  • Appropriate treatment significantly improves pregnancy outcomes in OAPS.
  • Long-term monitoring for thrombotic risks is essential for OAPS survivors.